MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,106,000 | -71.7% | 9,687 | -68.0% | 0.01% | -71.1% |
| Q1 2015 | $3,909,000 | +15.0% | 30,288 | -11.3% | 0.04% | +15.4% |
| Q4 2014 | $3,400,000 | -11.8% | 34,137 | -12.5% | 0.04% | -15.2% |
| Q3 2014 | $3,857,000 | +28.3% | 39,015 | 0.0% | 0.05% | +31.4% |
| Q2 2014 | $3,007,000 | +19.8% | 39,015 | 0.0% | 0.04% | +16.7% |
| Q1 2014 | $2,511,000 | +2.8% | 39,015 | +1.9% | 0.03% | +7.1% |
| Q4 2013 | $2,442,000 | – | 38,270 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |